Skip to main content
SpringerLink
Log in

Cancers of the Kidney and Urinary Tract

  • Chapter
Therapy of Renal Diseases and Related Disorders

  • 174 Accesses

Abstract

Over the past two decades we have witnessed a remarkable change in the management of cancer. While the results of treatment with each modality—surgery, radiotherapy, chemotherapy, and immunotherapy—have improved, the most dramatic successes have resulted from combining two or more of these approaches. Integrated, multimodal therapy can now offer substantial control of testicular cancers, lymphomas, Wilms’ tumors, and others, and has yielded dramatic improvements for osteogenic and soft-tissue sarcomas and for breast, ovarian, and head and neck cancers (1). Improved management of malignant tumors of the urinary tract has also contributed to these advances. Combinations of surgery and chemotherapy are commonly used now for transitional cell carcinomas of the renal pelvis, ureter, and bladder. Topical applications of chemotherapy, combined with surgical resection, have become highly effective in controlling superficial bladder tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. DeVita VT Jr, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology, 2nd ed. JB Lippincott, Philadelphia, 1982.

    Google Scholar 

  2. Wallace AC, Nairn RC: Renal tubular antigens in kidney tumors. Cancer 29:977–981, 1972.

    Article  PubMed  CAS  Google Scholar 

  3. Bennington JL, Laubsch FA: Epidemiologic studies on carcinoma of the kidney: Association of renal adenocarcinoma with smoking. Cancer 21:1069, 1986.

    Article  Google Scholar 

  4. Morrison AS, Cole P: Epidemiology of urologic cancers. In: N Javadpour, ed, Principles and Management of Urologic Cancer. Williams and Wilkins, Baltimore, pp 1–27, 1979.

    Google Scholar 

  5. Bennington JL, Beckwith JB: Tumors of the kidney, renal pelvis and ureter. In: Atlas of Tumor Pathology, Fascide 12, Washington, DC, Armed Forced Institute of Pathology, 1975.

    Google Scholar 

  6. DeKernion JB, Berry D: The diagnosis and treatment of renal cell carcinoma. Cancer 45:1947–1956, 1980.

    PubMed  CAS  Google Scholar 

  7. Paulson DF, Perez CA, Anderson T: Cancer of the kidney and ureter. In:VT DeVita Jr, S Hellman, SA Rosenberg, eds, Cancer: Principles and Practice of Oncology, 2nd ed, JB Lippincott, Philadelphia, pp 895–915, 1985.

    Google Scholar 

  8. Silverberg E, Boring CC, Squires TS: Cancer statistics, 1990. CA 40:9–26, 1990.

    PubMed  CAS  Google Scholar 

  9. Skinner DG, Colvin RB, Vermillion CD, Pfister RC, Leadbetter WF: Diagnosis and management of renal cell carcinoma. A clinical and pathological study of 309 cases. Cancer 28:1165–1177, 1971.

    Article  PubMed  CAS  Google Scholar 

  10. Goncharenko V, Gerlock AJ Jr, Kadir S, Turner B: Incidence and distribution of venous extension in 70 hypernephromas. Am J Radiol 133:263–265, 1979.

    CAS  Google Scholar 

  11. Kradjian RM, Bennington JL: Renal carcinoma: Recurrent 31 years after nephrectomy. Arch Surg 90:192–195, 1965.

    PubMed  CAS  Google Scholar 

  12. Lieber MM, Tomera KM, Farrow GM: Renal oncocytoma. J Urol 125:418–485, 1982.

    Google Scholar 

  13. Marshall FF, Walsh, PC: Extrarenal manifestations of renal cell carcinoma. J Urol 117:439–440, 1977.

    PubMed  CAS  Google Scholar 

  14. Nishijima Y, Noguchi R, Ishikawa S, Nemoto R, Kanoh N, Koiso K: Renal cell carcinoma as an incidental finding by ultrasonography and computed tomography (abstract). J Urol 139:423A, 1988.

    Google Scholar 

  15. Skinner D, Lieskovsky G, Pritchett T: In: D Skinner, G Lieskovsky, eds, Diagnosis and Management of Genitourinary Cancer. WB Saunders, Philadelphia, 1988.

    Google Scholar 

  16. Marshall FF, Reitz BA, Diamon DA: A new technique for management of renal cell carcinoma involving the right atrium: Hypothermia and cardiac arrest. J Urol 131:103–107, 1984.

    PubMed  CAS  Google Scholar 

  17. Quesada JR, Swanson DA, Trindade A, Gutterman JV: Renal cell carcinoma: Antitumor effects of leukocyte interferon. Cancer Res 43:940–947, 1983.

    PubMed  CAS  Google Scholar 

  18. Rosenberg SA, et al.: Observations on the systemic administration of autologous lymphokine activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med 313:1485, 1985.

    Article  PubMed  CAS  Google Scholar 

  19. Gittes, RF: Tumors of the ureter and renal pelvis. In: JH Harrison, RF Gittes, AD Perlmutter, T Stamey, PC Walsh, eds, Campbells Urology, 4th ed. WB Saunders, Philadelphia, pp 1010–1032, 1979.

    Google Scholar 

  20. Bergman H, Hotchkiss RS: Ureteral tumors. In: H Bergman, ed, The Ureter, 2nd ed. Springer-Verlag, New York, pp 271–300 1981.

    Google Scholar 

  21. Johnson, DE: Renal pelvic and ureteral tumors: In: DE Johnson, MA Boileau, eds, Genitourinary Tumors: Fundamental Principles and Surgical Techniques. Grune and Stratton, New York, pp 353–370, 1982.

    Google Scholar 

  22. Clayman RV, Lange PH, Fraley, EE: Cancer of the upper urinary tract. In: N Javadpour, ed, Principles and Management of Urologie Cancer, 2nd ed. Williams and Wilkins, Baltimore, pp 544–559, 1983.

    Google Scholar 

  23. Richie JP: Management of ureteral tumors. In: DG Skinner, JB deKernion, eds, Genitourinary Cancer. WB Saunders, Philadelphia, pp 150–165, 1978.

    Google Scholar 

  24. Lomax-Smith JD, Seymour AE: Neoplasia in analgesic nephropathy. A urothelial field change. Am J Surg Pathol 4:565–572, 1980.

    Article  PubMed  CAS  Google Scholar 

  25. Petkovic SD: Treatment of bilateral renal pelvis and ureteral tumors. Eur Urol 4:391–400, 1979.

    Google Scholar 

  26. Cummings KB, Correa RJ, Gibbons RP: Renal pelvic tumors. J Urol 113:158–162, 1977.

    Google Scholar 

  27. Mahadevia PS, Karwa GL, Koss LG: Mapping of urothelium in carcinomas of the renal pelvis and ureter. Cancer 51:890–897, 1983.

    Article  PubMed  CAS  Google Scholar 

  28. Cummings KB: Nephroureterectomy: Rationale in the management of transitional cell carcinoma of the upper urinary tract. Urol Clin North Am 7:569–578, 1980.

    PubMed  CAS  Google Scholar 

  29. Johansson S, Wahlqvist L: A prognostic study of urothelial renal pelvic tumors. Cancer 43:2525–2531, 1979.

    Article  PubMed  CAS  Google Scholar 

  30. Cancer Statistics, 1983. Cancer 33:9–25, 1983.

    Google Scholar 

  31. Morrison AS, Cole P, Maclure KM: Epidemiology of urologic cancers. In: N Javadpour, ed, Principles and Management of Urologic Cancer. Williams and Wilkins, Baltimore, pp 12–31, 1983.

    Google Scholar 

  32. Skinner DG: Current state of classification and staging of bladder cancer. Cancer Res 37:2838–2842, 1977.

    PubMed  CAS  Google Scholar 

  33. DeKernion JB, Skinner DG: Epidemiology, diagnosis and staging of bladder cancer. In: DG skinner, JB DeKernion, eds, Genitourinary Cancer. WB Saunders, Philadelphia, pp 213–231, 1978.

    Google Scholar 

  34. Johnson DE, Boileau MA: Bladder Cancer: Overview. In: DE Johnson, MA Boileau, eds, Genitourinary Tumors: Fundamental Principles and Surgical Techniques. Grune and Stratton, New York, pp 399–447, 1982.

    Google Scholar 

  35. Gittes, RF: Tumors of the bladder. In: JH Harrison, RF Gittes, AD Perlmutter, T Stamey, PC Walsh, eds, Campbell’s Urology, 4th ed. WB Saunders, Philadelphia, pp 1033–1070, 1979.

    Google Scholar 

  36. Utz, DC, DeWeerd JH: The management of low-grade low-stage carcinoma of the bladder. In: DG Skinner, JB DeKernion, eds, Genitourinary Cancer. WB Saunders, Philadelphia, pp 256–268, 1978.

    Google Scholar 

  37. Heney NM, Daly J, Prout GR et al.: Biopsy of apparently normal urothelium in patients with bladder cancer. J Urol 120:559, 1978.

    PubMed  CAS  Google Scholar 

  38. Newman AJ Jr, Carlton CE Jr, Johnson S: Cell surface A, B, or O(H) blood group antigens as an indication of malignant potential in stage A bladder carcinoma. J Urol 124:27–29, 1980.

    PubMed  Google Scholar 

  39. Murphy WM, Emerson LD, Chandler RW et al.: Flow cytometry versus urinary cytology in the evaluation of patients with bladder cancer. J Urol 136:815–819, 1986.

    PubMed  CAS  Google Scholar 

  40. deVere White RW, Olson CR, Dietrich AD: Flow cytometry: Role in monitoring transitional cell carcinoma of the bladder. Urology 28:15–20, 1986.

    Article  PubMed  CAS  Google Scholar 

  41. Skinner DG: Current perspectives in the management of high-grade invasion of invasive bladder cancer. Cancer 45:1866–1874, 1980.

    PubMed  CAS  Google Scholar 

  42. Soloway MS: The management of superficial bladder cancer. Cancer 45:1856–1865, 1980.

    PubMed  CAS  Google Scholar 

  43. Utz DC, Farrow CM, Rife CC, Segura JW, Zincke H: Carcinoma in situ of the bladder. Cancer 45:1842–1848, 1980.

    PubMed  CAS  Google Scholar 

  44. Utz DC, Schmitz SE, Fugelo PD, Farrow GM: A clinico-pathologic evaluation of partial cystectomy for carcinoma of the urinary bladder. Cancer 32:1075, 1973.

    Article  PubMed  CAS  Google Scholar 

  45. Skinner, DG, Kauffman JJ: The management of invasive and high grade bladder cancer. In: DG Skinner, JB DeKernion, eds, Genitourinary Cancer. WB Saunders, Philadelphia, pp 269–283, 1978.

    Google Scholar 

  46. Skinner DG: Radical cystectomy. In: ED Crawford, TA Borden, eds, Genitourinary Cancer Surgery. Lea and Febi-ger, Philadelphia, pp 207–216, 1982.

    Google Scholar 

  47. Van der Werf-Messing B: Cancer of the urinary bladder treated by interstitial radium implant. Int J Radiat Oncol Biol Physiol 4: 373–378, 1978.

    Google Scholar 

  48. Miller LS: Bladder cancer: Superiority of preoperative irradiation and cystectomy in clinical stages B2 and C. Cancer 39:973–980, 1977.

    Article  PubMed  CAS  Google Scholar 

  49. Whitmore WF Jr, Batata MA, Oheneum MA, Grabstald H, Unal A: Radical cystectomy with or without prior irradiation in the treatment of bladder cancer. J Urol 108:184, 1977.

    Google Scholar 

  50. Prout GR Jr: The surgical management of bladder carcinoma. Urol Clin North Am 3:149–175, 1976.

    PubMed  Google Scholar 

  51. Scardino PT, Skinner DG: Radical cystectomy, pelvic lymph node dissection, and urethrectomy. In: ED Whitehead, ed, Current Operative Urology, 2nd ed. Harper & Row, Hager-stown, MD, 1984.

    Google Scholar 

  52. Mathur VK, Krahn HP, Ramsey EW: Total cystectomy for bladder cancer J Urol 125:784–786, 1981.

    PubMed  CAS  Google Scholar 

  53. Schwartz S, Yagoda A, Natale RB, Watson RC, Whitmore WF Jr, Lesser M: Phase II trial of sequentially administered cisplatin, cyclophosphamide and doxorubicin for urothelial tract tumors. J Urol 130:681–684, 1983.

    PubMed  CAS  Google Scholar 

  54. Sternberg CN, Yagoda A, Scher HI, Watson RC et al.: Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin, and cisplatin) for transitional cell carcinoma of the urothelium. J Urol 133:403–407, 1985.

    PubMed  CAS  Google Scholar 

  55. Koch NG, Nilson AE, Nilson LO, Norlen LJ, Philipson BM: Urinary diversion via continent ileal reservoir: Clinical results in 12 patients. J Urol 128:469–475, 1982.

    Google Scholar 

  56. Richie JP: Techniques of ureterointestinal anastomoses and conduit construction. In: ED Crawford, TA Borden, eds, Genitourinary Cancer Surgery, Lea & Febiger, Philadelphia, pp 227–239, 1982.

    Google Scholar 

  57. Seidman H, Mushinski MH, Geib SK, Silverberg E: Probabilities of eventually developing or dying of cancer— United States, 1985, CA 35:36–56, 1985.

    Article  PubMed  CAS  Google Scholar 

  58. Frank LM: Latent carcinoma of the prostate. J Path Bacter-iol 68:603, 1954.

    Article  Google Scholar 

  59. McNeal JE: Origin and development of carcinoma in the prostate. Cancer 23:24, 1969.

    Article  PubMed  CAS  Google Scholar 

  60. Scardino PT: Early detection of prostate cancer. Urol Clin N Am 14:1170–1191, 1989.

    Google Scholar 

  61. Gleason DF, Mellinger GT, the VACRUG: Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 111:58–64, 1974.

    PubMed  CAS  Google Scholar 

  62. Wheeler TM: Anatomical consideration in carcinoma of the prostate. Urol Clin North Am 16:623–634, 1989.

    PubMed  CAS  Google Scholar 

  63. Whitmore WF: The natural history of prostatic cancer. Cancer 32:1104–1112, 1973.

    Article  PubMed  Google Scholar 

  64. Huggins C, Stevens RE, Hodges CV: Studies on prostatic cancer. II. The effect of castration on clinical patients with carcinoma of the prostate. Arch Surg 43:208–223, 1941.

    Google Scholar 

  65. Jobsis AC, DeVries GP, Anholt RRH, et al.: Demonstration of prostatic origin of metastases. An immunochemical method for formaline-fixed embedded tissue. Cancer 41:1788, 1978.

    Article  PubMed  CAS  Google Scholar 

  66. Guinan P, Bush I, Ray R, Veth R, Rao R, Bhatti R: The accuracy of the rectal examination in the diagnosis of prostate carcinoma N Engl J Med 303:499–502, 1980.

    Article  PubMed  CAS  Google Scholar 

  67. Walsh PC, Lepor H: The role of radical prostatectomy in the management of prostatic cancer. Cancer 60 (Suppl 3):526–537, 1987.

    Article  PubMed  CAS  Google Scholar 

  68. Lee F, Torp-Pedersen ST, Siders DB, Littrup PJ, McLeary RD: Transrectal ultrasonography in the diagnosis and staging of prostatic carcinoma. Radiology 170:609–615, 1989.

    PubMed  CAS  Google Scholar 

  69. Shinohara K, Wheeler T, Scardino PT: The appearance of prostate cancer on transrectal ultrasonography: Correlation of imaging and pathological examinations. J Urol 142:76–82, 1989.

    PubMed  CAS  Google Scholar 

  70. Lee F, Littrup PJ, Torp-Pedersen ST, Mettlin C, McHugh TA, Gray JM, Kumasada GH, McLeary RD: Prostate cancer: Comparison of transrectal US and digital rectal examination for screening. Radiology 168:389–394, 1988.

    PubMed  CAS  Google Scholar 

  71. Lee F, Torp-Pedersen S, Littrup PJ, McLeary RD, McHugh TA, Smid AP, Stella PJ, Borlaza GS: Hypoechoic lesions of the prostate: Clinical relevance of tumor size, digital rectal examination, and prostate-specific antigen. Radiology 170:29–32, 1989.

    PubMed  CAS  Google Scholar 

  72. Gittes RF: Serum acid phosphatase and screening for carcinoma of the prostate. N Engl J Med 309:852–853, 1983.

    Article  PubMed  CAS  Google Scholar 

  73. Cooper JF: The radioimmunochemical measurement of prostatic acid phosphatase: Current state of art. Urol Clin North Am 7:653–665, 1980.

    PubMed  CAS  Google Scholar 

  74. Bruce AW, Mahan DE, Belville WD: The role of the radioimmunoassay for prostatic acid phosphatase in prostatic carcinoma. Urol Clin North Am 7:645–652, 1980.

    PubMed  CAS  Google Scholar 

  75. Andriole GL, Catalona W: Controversies in urologic oncology. Urol Clin North Am 14(4):657, 1987.

    PubMed  CAS  Google Scholar 

  76. Wang MC, Papsidero LD, Kurtyama M, Valenzucla LA, Murphy GP, Chu FM: Prostatic antigen: A new potential marker for prostatic cancer. Prostate 2:89, 1981.

    Article  PubMed  CAS  Google Scholar 

  77. Papsidero LD, Wang MC, Valenzucla LA et al: A prostate specific antigen in SCR A of prostatic cancer patients. Cancer Res 40:2428, 1980.

    PubMed  CAS  Google Scholar 

  78. Myrtle JF, Klimey PG, Iwor LP, Bruni JF: Clinical utility of prostate specific antigen (PSA) in the management of prostate cancer. Adv Cancer Diagn, 1986.

    Google Scholar 

  79. Kuriyama M, Wang MC, Lee CL, Kilian CS, Papsidero LD, Inaji H, Loor RM, Lin MF, Nishuria T, Slack NH, Murphy GP, Chu TM: Multiple marker evaluation in human prostate cancer with the use of tissue specific antigens. J Natl Cancer Inst 68: 99, 1982.

    PubMed  CAS  Google Scholar 

  80. Killian CL, Yang N, Emirch LJ, Vargas FP, Kuriyama M, Wang MC, Slack NH, Papsidero LC, Murphy GP, Chu TM, the investigators of the National Prostatic Cancer Project: Prognostic significance of prostate specific antigen for monitoring patients with stages B2 to Dl prostate cancer. Cancer Res 45:886, 1985.

    PubMed  CAS  Google Scholar 

  81. Ercole CJ, Lange PH, Mathisen M, Chiou RK, Reddy PK, Vessella RL: Prostatic specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer J Urol 138:1181, 1987.

    PubMed  CAS  Google Scholar 

  82. Ferro PJB: Tumour markers in prostatic carcinoma: A comparison of prostate specific antigen with acid phosphatase. Br J Urol 60:69, 1987.

    Article  PubMed  CAS  Google Scholar 

  83. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E: Prostate specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 317:909, 1987.

    Article  PubMed  CAS  Google Scholar 

  84. Chan DW, Bruzek DJ, Oesterling JE, Rock RC, Walsh PC: Prostate specific antigen as a marker for prostatic cancer: A monoclonal and polyclonal immunoassay compared. Clin Chem 33:1916, 1987.

    CAS  Google Scholar 

  85. Stamey TA: Editorial comment. J Urol 139:764, 1988.

    Google Scholar 

  86. Lange PH, Ercole CJ, Lightner DJ, Fraley EE: The value of serum prostatic specific antigen determinations before and after radical prostatectomy. J Urol 141:873–879, 1989.

    PubMed  CAS  Google Scholar 

  87. Wang TY, Kawaguichi TP: Preliminary evaluation of measurement of serum prostate specific antigen level in detection of prostate cancer. Ann Clin Lab Sci 16:461, 1986.

    PubMed  CAS  Google Scholar 

  88. Oesterling JE, Chan DW, Epstein JI, Kimball AW Jr, Bruzek DJ, Rock RC, Brendler CB, Walsh PC: Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy. J Urol 139:766, 1988.

    PubMed  CAS  Google Scholar 

  89. Cooner WH, Mosley BR, Rutherford CL Jr, Beard JH, Pond HS, Bass RB, Terry WJ: Clinical application of transrectal ultrasonography and prostate-specific antigen in the search for prostate cancer. J Urol 139:66–69, 1988.

    Google Scholar 

  90. Brawer MK, Lange PH: Prostate-specific antigen: Its role in early dectection, staging, and monitoring of patients with prostatic carcinoma. J Endourol 3:227–236, 1989.

    Article  Google Scholar 

  91. Whitmore WF Jr: Hormone therapy in prostatic cancer. Am J Med 21:697, 1956.

    Article  PubMed  Google Scholar 

  92. Whitmore WF Jr, Catalona WJ, Grayhack JT, Hanks G, Peters PC, Shipley WV, Walsh PC: Organ systems program staging classification for prostate cancer. In: A Multidisci-plinary Analysis of Controversies in the Management of Prostate Cancer. DS Coffey, MI Resnick, FA Dorr, JP Karr, eds, Plenum Press, New York, pp 295–297, 1988.

    Chapter  Google Scholar 

  93. Neerhut GJ, Wheeler TM, Dunn JK et al.: Residual tumor after TUR: Pathologic features of stage A prostate cancer in the transurethral and radical prostatectomy specimens. J Urol 139:315A, 1988.

    Google Scholar 

  94. Schmidt JD, Mettlin CJ, Natarajan N, Peace BB, Beart Robert W Jr, Winchester DP, Murphy P: Trends in patterns of care for prostatic cancer, 1974–1983: Results of surveys by the American College of Surgeons. J Urol 136:416–421, 1986.

    PubMed  CAS  Google Scholar 

  95. Newman AJ Jr, Graham MA, Carlton CE Jr, Lieman S: Incidental carcinoma of the prostate at the time of transurethral resection: Importance of evaluating every chip. J Urol 128:948–950, 1982.

    PubMed  Google Scholar 

  96. Cantrell BB, DeKlerk DP, Eggleston JC, Boitnott SK, Walsh PC: Pathologic factors that influence prognosis in stage A prostatic cancer: The influence of extent versus grade. J Urol 125:516, 1981.

    PubMed  CAS  Google Scholar 

  97. Donohue RE, Mani JH, Whitesel JA, Mohr S, Scanavino D, Augsburger RR, Biber RJ, Fauver EH, Wettlaufer JN, Pfister RR: Pelvic lymph node dissection: Guide to patient management in clinically locally confined adenocarcinoma of prostate. Urology 20:559–565, 1982.

    Article  PubMed  CAS  Google Scholar 

  98. Blute ML, Zincke H, Farrow GM: Long-term follow-up of young patients with stage A adenocarcinoma of the prostate. J Urol 136:840–843, 1986.

    PubMed  CAS  Google Scholar 

  99. Carlton CE Jr, Scardino PT: Long-term results after combined radioactive gold seed implantation and external beam radiotherapy for localized prostatic cancer. In: A Multidisci-plinary Analysis of Controversies in the Management of Prostate Cancer. DS Coffey, MI Resnick, FA Dorr, JP Karr, eds, Plenum, New York, pp 109–121, 1988.

    Chapter  Google Scholar 

  100. Lin BP, Davies WE, Harmata PA: Prostatic aspiration cytology. Pathology 11:607–614, 1979.

    Article  PubMed  CAS  Google Scholar 

  101. Lee F, Littrup PJ, McLeary RD, Kumasaka GH, Borlaga GS, McHugh TA, Soideren MH, Roi LD: Needle aspiration and core biopsy of prostate cancer: Comparative evaluation with biplanar transrectal US guidance. Radiology 163:515–520, 1987.

    PubMed  CAS  Google Scholar 

  102. Shabsigh R, Carter S StC, Egawa S, Wright CD, Carlton CE Jr, Scardino PT: Transrectal ultrasound and/or digital guided biopsy of the prostate. J Urol 141:282A, 1989.

    Google Scholar 

  103. Scardino PT, Shinohara K, Carter S StC, Wheeler TM: Staging of prostate cancer: The value of ultrasonography. Urol Clin North Am 16:713–734, 1989.

    PubMed  CAS  Google Scholar 

  104. Walsh PC, Donker PJ: Impotence following radical prostatectomy: Insight into etiology and prevention. J Urol 128:492–497, 1982.

    PubMed  CAS  Google Scholar 

  105. Bagshaw MA: Radiation therapy of prostatic carcinoma. In: ED Crawford, TA Borden, eds, Genitourinary Cancer Surgery. Lea and Febiger, Philadelphia, pp 405–411, 1982.

    Google Scholar 

  106. Grossman HB, Batata M, Hilaris B, Whitmore WF Jr:125I implantation for carcinoma of the prostate. Urology 20:291, 1982.

    Google Scholar 

  107. The Leuprolide Study Group: Leuprolide versus DES in the initial therapy of advanced prostatic cancer: A randomized prospective trial. N Engl J Med 311:1281, 1984.

    Article  Google Scholar 

  108. Crawford ED, McLeod D, Dorr H, et al.: A comparison of leuprolide with flutamide and leuprolide in previously untreated patients with clinical stage D2 cancer of the prostate. Phase III, Intergroup Study—0036. N Engl J Med 254:1989.

    Google Scholar 

  109. Scott WW, Menon M, Walsh PC: Hormonal therapy of prostatic cancer. Cancer 45:1929–1936, 1980.

    PubMed  CAS  Google Scholar 

  110. Gibbons RP: Cooperative clinical trials of single and combined agent protocols: Adjuvant protocols. Urology 17 (Suppl):48–52, 1981.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. Peter T. Scardino
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Madeline Cantini
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Baylor College of Medicine, The Methodist Hospital, Houston, Texas, USA

    Wadi N. Suki

  2. Division of Nephrology, University of Southern California, Los Angeles, California, USA

    Shaul G. Massry

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Kluwer Academic Publishers

About this chapter

Cite this chapter

Scardino, P.T., Cantini, M. (1991). Cancers of the Kidney and Urinary Tract. In: Suki, W.N., Massry, S.G. (eds) Therapy of Renal Diseases and Related Disorders. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0689-4_38

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-0689-4_38

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-8027-9

  • Online ISBN: 978-1-4613-0689-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation